Tumour necrosis factor alpha and mucocutaneous leishmaniasis (Q33611149)

28 July 2017

1 reference

title

Tumour necrosis factor alpha and mucocutaneous leishmaniasis (English)

1 reference

mucocutaneous leishmaniasis

28 July 2017

0 references

1 reference

Blackwell JM

1

1 reference

28 July 2017

1 February 1999

1 reference

28 July 2017

Trends in Parasitology

1 reference

28 July 2017

15

1 reference

28 July 2017

2

1 reference

28 July 2017

73-75

1 reference

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumour necrosis factor microsatellites show association with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumour necrosis factor haplotypes and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Suppression of tumour necrosis factor-alpha expression in leprosy skin lesions during treatment for leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

The place of thalidomide in the treatment of inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Taming TNF: strategies to restrain this proinflammatory cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Anticytokine therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901355-6

7 January 2021

10.1016/S0169-4758(98)01355-6

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10234190